Dapirolizumab pegol is an investigational Fc-free polyethylene glycol-conjugated antigen-binding fragment that inhibits CD40 ligand signaling.

Among the novel biological agents for lupus nephritis, renal response within a specific therapeutic time window improves with obinutuzumab, abatacept, and belimumab, investigators report.

AbbVie (NYSE: ABBV) today announced positive results from a new post-hoc analysis from the Measure Up 1 and Measure Up 2 Phase 3 studies. The analysis evaluated the efficacy of upadacitinib (15 mg or ...

Three different versions of Alexandria Wingate appear in a trio of purple paintings the Baltimorean started while a fine art ...

A U.S. judge ruled that Regeneron Pharmaceuticals cannot immediately block U.S. sales of a proposed copy of its blockbuster ...

Biogen and Belgian partner UCB said on Tuesday their experimental lupus treatment met the main goal of a late-stage trial in ...

Ilaris, which treats conditions including Still’s disease, can cause side effects such as unexpected weight gain. Learn about ...

Research connects gut microbiota to lupus and IBD, uncovering microbial markers and pathways that could inform targeted ...

A new study takes a look at a controversial medication recommended by some in the early days of the COVID-19 pandemic. KYW ...

Symptoms may range from mild to severe and can affect multiple body systems ... Weight loss may also occur as a result of the ...

Actress Selena Gomez is unable to carry a child to term without risk her or the baby's life. A disease called lupus is to ...

Use of a multidisciplinary care management pathway may improve pregnancy outcomes among women with SLE who previously had adverse obstetric outcomes.